Thus, although GH treatment either to mother or fetus in the sheep had variable impact and was possibly detrimental to offspring outcome, more positive effects have been shown in these models using fetal intra-amniotic IGF-1 treatment [75,76], with improved growth rates following IUGR independent of changes in fetal plasma IGF-1 or insulin concentrations. This evidence concerns the gene GH1 and fetal growth restriction.